Mivtach Shamir Holdings

Mivtach Shamir Holdings is a diversified public holding company based in Tel Aviv that deploys growth capital into mature medical technology operations alongside real estate and other holdings. The mixed-portfolio structure means healthcare is one of several lines of business, so founders should not expect a dedicated medtech operating team or a deeply specialist diligence process. The firm typically partners with established venture syndicates for sector expertise.

Stages listed are Growth, with check sizes between $5 million and $25 million. Sub-verticals are pharma and medical devices. The record does not name specific portfolio companies. Activity is concentrated in Israel, with deal flow likely sourced through co-investment with the local healthcare VC ecosystem.

For founders, Mivtach Shamir is most useful as a co-investor in a later round when a specialist healthcare lead is already in place. It is unlikely to be the right firm to lead a clinical or AI software round on its own, but can be a useful capital partner for a Series B or growth round that needs Israeli balance-sheet capital alongside specialist VCs. Healthcare AI founders without a hardware or pharma anchor are less likely to fit. Founders should arrive with a clean syndicate map and a clear ask rather than expecting the firm to drive the round.